Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply
Publication date
2020-08
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Cyclophosphamide, Doxorubicin, Humans, Lymphoma, Non-Hodgkin, Prednisone, Rituximab, Vincristine, Taverne, Letter, Comment
Citation
Linschoten, M, Kamphuis, J A & Asselbergs, F W 2020, 'Cardiovascular adverse events following treatment for non-Hodgkin lymphoma - Authors' reply', The Lancet. Haematology, vol. 7, no. 8, pp. e557-e558. https://doi.org/10.1016/S2352-3026(20)30228-3